4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0000905148-23-001091
Chief Regulatory Officer sold 5,000 shares at an average $46.62 ($233,084)
- Chief Regulatory Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karp Carol D. Chief Regulatory Officer | 2023-10-04 | Option exercise 10b5-1 | +5,000 | $12.15 | $60,750 | 5,000 | D |
| Karp Carol D. Chief Regulatory Officer | 2023-10-04 | Sale 10b5-1 | −4,337 | $46.51 | $201,729 | 663 | D |
| Karp Carol D. Chief Regulatory Officer | 2023-10-04 | Sale 10b5-1 | −663 | $47.29 | $31,355 | 0 | D |
| Derivatives | |||||||
| Karp Carol D. Chief Regulatory Officer | 2023-10-04 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 45,000 | D | ||
| Open-market sales · 5,000 sh · avg $46.62 · $233,084 | |||||||
Loading xslF345X05/form4.xml…